Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Address Pharmacy Medication Regimen Review Recommendations

Aurora, Illinois Survey Completed on 04-23-2025

Penalty

Fine: $111,25532 days payment denial
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to address pharmacy medication regimen review (MRR) recommendations for two residents reviewed for unnecessary medications. For one resident with multiple chronic conditions, including COPD, heart failure, and morbid obesity, the pharmacist repeatedly recommended reviewing the continued need for scheduled guaifenesin and the appropriateness of a long-standing as-needed lorazepam order. Despite these recommendations, there was no documentation that the physician or facility staff reviewed or acted upon them, and the resident continued to receive guaifenesin as scheduled, while lorazepam had not been administered for several months. For another resident with vascular dementia, schizoaffective disorder, and other neurological conditions, the pharmacist recommended assessing the need for a valproic acid level and considering vitamin D supplementation due to a low lab value. The MRR forms for this resident were not signed off by the attending physician, and there was no documentation that the recommendations were reviewed or addressed. Interviews confirmed that the staff member responsible for receiving pharmacy recommendations was unavailable, and the facility's policy required staff to act upon all MRR recommendations, which was not followed in these cases.

An unhandled error has occurred. Reload 🗙